Detalhe da pesquisa
1.
Drug-regulated CD33-targeted CAR T cells control AML using clinically optimized rapamycin dosing.
J Clin Invest
; 134(9)2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502193
2.
INBRX-120, a CD8α-targeted detuned IL-2 that selectively expands and activates tumoricidal effector cells for safe and durable in vivo responses.
J Immunother Cancer
; 11(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36653071
3.
Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma.
Clin Cancer Res
; 29(16): 2988-3003, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37265425